AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2013
Sep 19, 2013
32566_dirs_2013-09-19_abe9a6af-caf1-4701-a2f4-ca9a1bef153a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-09-17
Reporting Person: Rogers Ronald S. (Exec VP Corp Communications)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-17 | Non-Qualified Stock Option (right to buy) | $26.49 | A | 50000 | Acquired | 2021-09-17 | Common Stock (50000) | Direct |
Footnotes
F1: Non-Qualified Stock Option
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2